These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17531484)

  • 1. Positional linker effects in haptens for cocaine immunopharmacotherapy.
    Ino A; Dickerson TJ; Janda KD
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4280-3. PubMed ID: 17531484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine pharmacology and current pharmacotherapies for its abuse.
    Carrera MR; Meijler MM; Janda KD
    Bioorg Med Chem; 2004 Oct; 12(19):5019-30. PubMed ID: 15351386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential.
    Lu Y; You F; Vlahov I; Westrick E; Fan M; Low PS; Leamon CP
    Mol Pharm; 2007; 4(5):695-706. PubMed ID: 17784727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rhodococcus sp. cocaine esterase: a bacterial candidate for novel pharmacokinetic-based therapies for cocaine abuse.
    Ascenzi P; Clementi E; Polticelli F
    IUBMB Life; 2003 Jul; 55(7):397-402. PubMed ID: 14584590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.
    Dickerson TJ; Janda KD
    AAPS J; 2005 Oct; 7(3):E579-86. PubMed ID: 16353936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.
    Kuhar MJ; Carroll FI; Bharat N; Landry DW
    Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic antibodies: hapten design strategies and screening methods.
    Xu Y; Yamamoto N; Janda KD
    Bioorg Med Chem; 2004 Oct; 12(20):5247-68. PubMed ID: 15388154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from a bacterial cocaine esterase.
    Bosron WF; Hurley TD
    Nat Struct Biol; 2002 Jan; 9(1):4-5. PubMed ID: 11753424
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies.
    Meijler MM; Kaufmann GF; Qi L; Mee JM; Coyle AR; Moss JA; Wirsching P; Matsushita M; Janda KD
    J Am Chem Soc; 2005 Mar; 127(8):2477-84. PubMed ID: 15725002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and therapeutic procedures with haptens and glycoproteins (antigens and antibodies) coupled covalently by specific sites to insoluble supports.
    Quash GA; Thomas V; Ogier G; el Alaoui S; Delcros JG; Ripoll H; Roch AM; Legastelois S; Gibert R; Ripoll JP
    Targeted Diagn Ther; 1989; 2():155-86. PubMed ID: 2519545
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy for the treatment of drug abuse.
    Kosten T; Owens SM
    Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of distinct chemical structures for the development of a methamphetamine vaccine.
    Moreno AY; Mayorov AV; Janda KD
    J Am Chem Soc; 2011 May; 133(17):6587-95. PubMed ID: 21473576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
    Brown ES; Gorman AR; Hynan LS
    J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
    Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
    Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hapten heterology for a specific and sensitive indirect enzyme-linked immunosorbent assay for organophosphorus insecticide fenthion.
    Zhang Q; Wang L; Ahn KC; Sun Q; Hu B; Wang J; Liu F
    Anal Chim Acta; 2007 Jul; 596(2):303-11. PubMed ID: 17631111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic haptens as probes of antibody response and immunorecognition.
    Shreder K
    Methods; 2000 Mar; 20(3):372-9. PubMed ID: 10694458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis.
    Isomura S; Wirsching P; Janda KD
    J Org Chem; 2001 Jun; 66(12):4115-21. PubMed ID: 11397142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.